Microplastics, airway inflammation, and chronic respiratory disease: A mechanistic links to COPD and Asthma
Journal of Current Biomedical Reports · 2026
DOI: 10.66224/jcbior.7.2.365 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Current Biomedical Reports, 2026. Verfasst von Maryam Alsadat Baniaghil und 3 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: COPD
Abstract (Originalsprache)
Microplastics (MPs) and nanoplastics (NPs) are increasingly recognized as ubiquitous environmental contaminants with potential implications for respiratory health. Inhalation represents an important route of exposure, and the detection of plastic particles in human lung tissue has provided direct evidence that these particles can reach the respiratory system. This narrative review summarizes current evidence on the potential mechanisms linking inhaled MPs and NPs to chronic airway inflammation, with particular emphasis on asthma and chronic obstructive pulmonary disease (COPD). Recent studies indicate that plastic particles can induce oxidative stress, mitochondrial dysfunction, epithelial barrier disruption, altered macrophage responses, and persistent inflammatory signaling. In experimental models of asthma, MPs and NPs may enhance allergen-induced airway inflammation through epithelial injury, alarmin release, T helper 2 (Th2)-associated responses, eosinophilic inflammation, airway hyperresponsiveness, and airway remodeling. Emerging COPD-related evidence suggests that MPs may interact with pathways involved in mitochondrial injury, ferroptosis, epithelial dysfunction, and chronic pulmonary inflammation. Moreover, the potential for MPs to adsorb or transport environmental contaminants, allergens, and other particulate pollutants raises the possibility that their respiratory effects may be amplified under realistic co-exposure conditions. Despite increasing mechanistic evidence, substantial uncertainty remains regarding environmentally relevant exposure levels, chronic human exposure, individual susceptibility, and causal relationships with asthma or COPD. Future research should therefore prioritize standardized exposure assessment, longitudinal epidemiological studies, and multi-pollutant experimental models to determine whether MPs represent independent disease-causing agents or clinically relevant modifiers of chronic airway disease.
Zitieren
APA
Baniaghil, M. A., Ryahi, A., Keikhaei, N., & Farrokhpour, M. (2026). Microplastics, airway inflammation, and chronic respiratory disease: A mechanistic links to COPD and Asthma. Journal of Current Biomedical Reports. https://doi.org/10.66224/jcbior.7.2.365
Vancouver
Baniaghil MA, Ryahi A, Keikhaei N, Farrokhpour M. Microplastics, airway inflammation, and chronic respiratory disease: A mechanistic links to COPD and Asthma. Journal of Current Biomedical Reports. 2026. doi:10.66224/jcbior.7.2.365
BibTeX
@article{Baniaghil2026,
author = {Baniaghil, Maryam Alsadat and Ryahi, Atoosa and Keikhaei, Niloofar and Farrokhpour, Mohsen},
title = {Microplastics, airway inflammation, and chronic respiratory disease: A mechanistic links to COPD and Asthma},
journal = {Journal of Current Biomedical Reports},
year = {2026},
doi = {10.66224/jcbior.7.2.365}
}
EUVIMED